What is the recommended treatment for a patient presenting with scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scabies Treatment

Permethrin 5% cream applied to all areas of the body from the neck down and washed off after 8-14 hours is the first-line treatment for uncomplicated scabies, with oral ivermectin (200 μg/kg, repeated in 2 weeks) as an equally effective alternative. 1, 2, 3

First-Line Treatment Options

For most patients with uncomplicated scabies, use permethrin 5% cream as topical first-line therapy:

  • Apply to entire body from neck down, including under fingernails, between fingers and toes, and all skin folds 1, 2
  • Leave on for 8-14 hours (typically overnight), then wash off thoroughly 1, 4
  • One application is generally curative in most cases 5
  • Permethrin is safe, effective, and less expensive than ivermectin 1

Oral ivermectin is equally recommended as first-line therapy:

  • Dose: 200 μg/kg body weight, repeated in 2 weeks 1, 2
  • Must be taken with food to increase bioavailability and epidermal penetration 1, 2
  • The second dose at 2 weeks is essential because ivermectin has limited ovicidal activity 1, 2
  • Particularly useful for institutional outbreaks, bedridden patients, or when topical application is impractical 6

Special Populations

Pregnant and lactating women:

  • Use permethrin 5% cream exclusively 1, 3, 5
  • Avoid ivermectin due to limited safety data in pregnancy, though human data suggest low risk 1
  • Never use lindane due to association with neural tube defects and accumulation in breast milk 1

Infants and young children:

  • Permethrin 5% cream is preferred and safe for infants ≥2 months old 5, 4
  • Apply to entire body INCLUDING head, neck, and scalp in infants and young children 5, 6
  • Avoid ivermectin in children weighing <15 kg due to potential neurotoxicity 5
  • Never use lindane in children <10 years old 1, 3

Immunocompromised patients:

  • Higher risk for crusted (Norwegian) scabies requiring more aggressive treatment 3
  • Monitor more closely as treatment failure rates are higher 2

Crusted (Norwegian) Scabies

This severe form requires aggressive combination therapy:

  • Topical: 5% permethrin cream applied daily for 7 days, then twice weekly until cure 2, 3
  • PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15 2, 3, 5
  • Single-application permethrin or single-dose ivermectin will fail 2
  • This population harbors thousands to millions of mites and is far more contagious than typical scabies 2

Alternative Treatments (When First-Line Options Fail or Are Unavailable)

Lindane 1% is now relegated to alternative status due to toxicity concerns:

  • Apply thinly from neck down, wash off after 8 hours 1, 3
  • Contraindications: children <10 years, pregnant/lactating women, extensive dermatitis, immediately after bathing 1, 3
  • Risk of seizures and aplastic anemia, especially with improper use 1
  • Resistance reported in some U.S. regions 1

Other alternatives:

  • Crotamiton 10% applied nightly for 2 consecutive nights, washed off 24 hours after second application 1, 7
  • Sulfur 6% ointment applied nightly for 3 nights 3
  • Benzyl benzoate 25% (87% cure rate but causes burning sensation in 43% of patients) 3

Critical Management Steps Beyond Medication

Treat all close contacts simultaneously:

  • Examine and treat all persons with sexual, close personal, or household contact within the preceding month 1, 2, 3
  • Treat even if asymptomatic to prevent reinfection 5
  • This is the most common cause of treatment failure 2, 3

Environmental decontamination:

  • Machine wash and dry all bedding, clothing, and towels using hot cycle 1, 2, 3
  • Alternatively, dry clean or remove from body contact for at least 72 hours 1, 2
  • Fumigation of living areas is unnecessary 1, 2, 3
  • Vacuum furniture and carpets 6

Trim fingernails short:

  • Mites commonly remain under fingernails 2, 7
  • Apply medication under nails using a toothbrush, then discard the brush 7

Follow-Up and Expected Course

Pruritus and rash may persist for up to 2 weeks after successful treatment:

  • This is due to ongoing hypersensitivity reaction to dead mites, NOT treatment failure 2, 3, 5
  • In clinical trials, approximately 75% of patients with persistent pruritus at 2 weeks had resolution by 4 weeks 4

Consider retreatment only if:

  • Symptoms persist beyond 2 weeks 2, 3, 5
  • Live mites are observed on examination 1, 2
  • New burrows appear 6

Reasons for treatment failure:

  • Failure to treat all close contacts simultaneously (most common) 2, 3
  • Inadequate application of topical treatment (missing scalp/face in infants, under nails, skin folds) 2, 6
  • Not repeating ivermectin dose at 2 weeks 2, 3
  • Reinfection from untreated contacts or inadequately decontaminated fomites 2, 3
  • True medication resistance (rare but emerging) 1, 6

Critical Pitfalls to Avoid

Application errors with topical permethrin:

  • Failing to apply to entire body surface from neck down 2, 6
  • Missing scalp and face in infants and young children 5, 6
  • Not applying under fingernails 7, 6
  • Washing off too soon (must leave on 8-14 hours) 1, 4

Ivermectin errors:

  • Not taking with food (reduces bioavailability) 1, 2
  • Skipping the second dose at 2 weeks 2, 3
  • Using in children <15 kg 5

Lindane misuse:

  • Applying immediately after bathing (increases absorption and seizure risk) 1, 3
  • Using in contraindicated populations 1, 3

Contact management failures:

  • Not treating asymptomatic household contacts 2, 5
  • Delaying treatment of contacts (must be simultaneous) 2

Expecting immediate symptom resolution:

  • Pruritus commonly persists 1-2 weeks post-treatment 2, 3, 4
  • Premature retreatment based on persistent itching alone leads to unnecessary medication exposure 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Scabies Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.